Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,463 total articles

Stryker announces leadership succession

Stryker announces leadership succession

Stryker Corporation announces a planned leadership transition effective January 1, 2027, with current CEO Kevin Lobo moving to Executive Chair of the Board and current President and COO Spencer Stiles becoming the new CEO. The transition follows a comprehensive succession planning process and aims to continue Stryker's growth and innovation as a gl…

Tri Pointe Homes Named to Best Workplaces in Construction List by Great Place To Work and Fortune for the Fifth Consecutive Year

Tri Pointe Homes Named to Best Workplaces in Construction List by Great Place To Work and Fortune for the Fifth Consecutive Year

Tri Pointe Homes has been named one of the Best Workplaces in Construction for the fifth year in a row by Great Place To Work and Fortune. This accolade reflects the company's strong culture, commitment to employee development, and inclusive work environment, reinforcing its leadership position in the U.S. homebuilding industry across 13 states and…

Upexi to Participate in Upcoming October Investor Conferences

Upexi to Participate in Upcoming October Investor Conferences

Upexi, Inc., a NASDAQ-listed digital asset treasury company focused on accumulating Solana cryptocurrency and developing consumer brands, announced its Chief Strategy Officer Brian Rudick will participate in multiple investor conferences in October 2026. The company aims to showcase its strategic initiatives in Solana asset acquisition and consumer…

PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases

PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases

PDS Biotechnology Corporation announced a virtual key opinion leader event featuring Dr. Jonathan M. Hernandez to discuss clinical outcomes from the PDS0301 Phase 2 trials targeting advanced liver-associated metastatic colorectal cancer, focusing on patients with immunotherapy-resistant microsatellite stable tumors. PDS0301 is an investigational IL…

Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company

Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company

Telomir Pharmaceuticals secured $5.6 million through a private investment in public equity, including a $1.0 million additional investment from billionaire John Paul DeJoria. The funds will support the clinical development of Telomir-Zn, an oral small-molecule epigenetic therapy entering Phase 1/2 trials for advanced triple-negative breast cancer a…

Genius Group Recommences Bitcoin Treasury Purchases

Genius Group Recommences Bitcoin Treasury Purchases

Genius Group Limited (NYSE American: GNS) has recommenced its Bitcoin treasury purchases, acquiring 10 Bitcoin for approximately $854,000, marking progress in its $1.2 billion dual treasury capital plan targeting significant investments in Bitcoin and AI assets by FY2031. This move follows a favorable court ruling lifting restrictions on the compan…

Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026

Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026

Odyssey Therapeutics announced that additional results from the induction period of its Phase 2a trial of OD-001, an oral RIPK2 scaffolding inhibitor for moderate to severe ulcerative colitis, will be presented orally at the upcoming UEG Week 2026. The company will also host a conference call to discuss these new data, underscoring progress in thei…

Mercury Introduces RES One, a Rugged Edge Server Engineered for Rapid Deployment and Superior Lifecycle Management

Mercury Introduces RES One, a Rugged Edge Server Engineered for Rapid Deployment and Superior Lifecycle Management

Mercury Systems introduced RES One, a next-generation rugged edge server designed for rapid deployment, modular upgrades, and reduced sustainment costs in harsh environments. The platform supports long life cycles needed for military and industrial applications by allowing technology refreshes without complete redesigns, and features advanced secur…

Green Circle Decarbonize Technology Planned to Enter AI Data Center Cooling Market with Proprietary Ultra-Low Energy Liquid Cooling Solutions

Green Circle Decarbonize Technology Planned to Enter AI Data Center Cooling Market with Proprietary Ultra-Low Energy Liquid Cooling Solutions

Green Circle Decarbonize Technology Limited (NYSE: GCDT) is expanding into the AI data center infrastructure market by developing next-generation ultra-low energy liquid cooling systems. Utilizing proprietary phase change materials and thermal engineering, the company aims to improve energy efficiency and reduce operational costs in high-density AI…

ParaZero and ThirdEye Unveil New Battlefield System Designed to Detect and Intercept Drones for Armored Vehicles

ParaZero and ThirdEye Unveil New Battlefield System Designed to Detect and Intercept Drones for Armored Vehicles

ParaZero Technologies Ltd. has partnered with ThirdEye Systems Ltd. to combine their technologies into a comprehensive counter-UAS system for armored vehicles. The integrated solution pairs ThirdEye's AI-driven Iron Web drone detection technology with ParaZero's DefendAir net-based drone interception system, offering a 360° detect-to-defeat capabil…

SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

SCYNEXIS completed a Phase 1 study of SCY-770, a novel oral AMPK activator for treating Autosomal Dominant Polycystic Kidney Disease (ADPKD). The drug was well tolerated with a favorable safety profile across doses higher than previously tested, supporting planned dose selection for the Phase 2 proof-of-concept trial expected to start in Q4 2026. S…

SunPower Breaks Ground on Reno AI Data Center

SunPower Breaks Ground on Reno AI Data Center

SunPower Inc. (Nasdaq: SPWR) has broken ground on a solar power system for an AI data center in Reno, Nevada, marking a strategic expansion into complex commercial solar projects. The project serves as a learning opportunity for the company and aims to enhance its commercial system capabilities under rigorous performance specifications. The CEO hig…

BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia

BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia

BridgeBio Pharma announced that the FDA has accepted and granted Priority Review to its New Drug Application for oral infigratinib, a targeted therapy for children with achondroplasia. The company’s Phase 3 PROPEL 3 trial demonstrated significant improvements in height velocity, body proportionality, and other health measures, supporting the drug's…

Allied Gold Reports Resource Growth and Mine Life Extension Potential from Exploration Program as the Kurmuk Mine Completes Commissioning and Begins Operations

Allied Gold Reports Resource Growth and Mine Life Extension Potential from Exploration Program as the Kurmuk Mine Completes Commissioning and Begins Operations

Allied Gold Corporation reports significant exploration success at its Kurmuk Mine, with extensions to mineralized zones and discovery of additional higher-grade ore prospects. The commissioning of the Kurmuk Mine is progressing with first ore expected in the grinding circuit imminently. Expanded resource estimates and ongoing exploration along mul…

Cerenome Launches CNSide® CSF Molecular Profile Tests

Cerenome Launches CNSide® CSF Molecular Profile Tests

Cerenome, Inc. announced the commercial launch of CNSide® CSF Molecular Profile tests for comprehensive DNA and RNA profiling of central nervous system cancers using cerebrospinal fluid. These new tests expand diagnostic capabilities beyond leptomeningeal metastases to include primary CNS tumors and hematologic malignancies, offering clinicians act…